Maravai LifeSciences Holdings, Inc. Increase (Decrease) in Accounts Receivable
Maravai LifeSciences Holdings, Inc. (MRVI) reported Increase (Decrease) in Accounts Receivable of $5.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$2.29M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $7.91M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $2.96M, a 74.09% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$5.12M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$12.82M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$14.36M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$84.39M, a 478.93% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $22.27M, a 68.36% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $5.63M 10-Q · filed 2026-08-07 | $8.59M derived: sum of 3 quarters · filed 2026-08-07 | $3.47M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $7.91M 10-Q · filed 2026-05-08 | $10.88M derived: sum of 2 quarters · filed 2026-05-08 | $5.76M derived: sum of 3 quarters · filed 2026-05-08 | $5.26M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.15M derived: sum of 2 quarters · filed 2026-02-26 | -$2.66M derived: sum of 3 quarters · filed 2026-08-07 | -$12.82M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$5.62M derived: sum of 2 quarters · filed 2026-08-07 | -$15.78M 10-Q · filed 2025-11-07 | -$4.35M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | -$501.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$10.66M 10-Q · filed 2026-08-07 | $769.00K derived: sum of 3 quarters · filed 2026-08-07 | -$5.25M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | -$10.16M 10-Q · filed 2026-05-08 | $1.27M derived: sum of 2 quarters · filed 2026-05-08 | -$4.75M derived: sum of 3 quarters · filed 2026-05-08 | -$6.64M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.41M derived: sum of 2 quarters · filed 2026-02-26 | $3.52M derived: sum of 3 quarters · filed 2026-02-26 | -$14.36M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$7.91M derived: sum of 2 quarters · filed 2025-11-07 | -$25.79M 10-Q · filed 2025-11-07 | -$25.70M 10-Q · filed 2024-11-12 | -$17.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$19.77M 10-Q · filed 2025-08-11 | -$15.86M 10-Q · filed 2024-08-08 | -$10.99M derived: sum of 3 quarters · filed 2026-02-26 | -$14.20M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$17.88M 10-Q · filed 2025-05-12 | -$9.10M derived: sum of 2 quarters · filed 2026-02-26 | -$12.31M derived: sum of 3 quarters · filed 2026-02-26 | -$19.87M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.57M derived: sum of 2 quarters · filed 2026-02-26 | -$1.99M derived: sum of 3 quarters · filed 2026-02-26 | -$84.39M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$3.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.77M derived: sum of 2 quarters · filed 2024-11-12 | -$93.18M 10-Q · filed 2024-11-12 | -$67.41M derived: sum of 4 quarters · filed 2025-03-18 | ||
| 2023-06-30 | -$7.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$89.97M 10-Q · filed 2024-08-08 | -$64.19M derived: sum of 3 quarters · filed 2025-03-18 | -$70.03M derived: sum of 4 quarters · filed 2025-03-18 | ||
| 2023-03-31 | -$82.41M 10-Q · filed 2024-05-09 | -$56.63M derived: sum of 2 quarters · filed 2025-03-18 | -$62.47M derived: sum of 3 quarters · filed 2025-03-18 | -$62.35M derived: sum of 4 quarters · filed 2025-03-18 | ||
| 2022-12-31 | $25.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $19.94M derived: sum of 2 quarters · filed 2025-03-18 | $20.05M derived: sum of 3 quarters · filed 2025-03-18 | $22.27M 10-K · filed 2025-03-18 | ||
| 2022-09-30 | -$5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$5.72M derived: sum of 2 quarters · filed 2023-11-08 | -$3.50M 10-Q · filed 2023-11-08 | $48.04M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.33M 10-Q · filed 2023-08-08 | $53.87M derived: sum of 3 quarters · filed 2024-02-29 | $36.25M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $2.22M 10-Q · filed 2023-05-09 | $53.76M derived: sum of 2 quarters · filed 2024-02-29 | $36.14M derived: sum of 3 quarters · filed 2024-02-29 | $1.80M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $51.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $33.92M derived: sum of 2 quarters · filed 2024-02-29 | -$421.00K derived: sum of 3 quarters · filed 2024-02-29 | $70.39M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | -$17.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$51.96M derived: sum of 2 quarters · filed 2022-11-04 | $18.85M 10-Q · filed 2022-11-04 | -$3.42M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | -$34.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $36.47M 10-Q · filed 2022-08-05 | $14.20M derived: sum of 3 quarters · filed 2023-02-28 | $59.87M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $70.81M 10-Q · filed 2022-05-06 | $48.54M derived: sum of 2 quarters · filed 2023-02-28 | $94.21M derived: sum of 3 quarters · filed 2023-02-28 | $93.87M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | -$22.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $23.40M derived: sum of 2 quarters · filed 2023-02-28 | $23.06M derived: sum of 3 quarters · filed 2023-02-28 | $33.14M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $45.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $45.33M derived: sum of 2 quarters · filed 2021-11-15 | $55.42M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | -$344.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $9.74M 10-Q · filed 2021-08-11 | ||||
| 2020-03-31 | $10.09M 10-Q · filed 2021-05-12 | |||||
| 2019-12-31 | $1.89M 10-K · filed 2022-03-01 |